Derek Norman is a Managing Director at Syngenta Ventures. He joined Syngenta Ventures in 2009 as one of the founding members. Prior to Syngenta, he was with Hatteras Ventures Partners, which invests primarily in early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, heathcare IT, and related opportunities in human medicine. Before joining Hatteras, Derek worked at Dean & Co., a strategy consulting firm. Derek serves as a director on the boards of Biognosys and two other undisclosed investments, and he is an observer to the board of Illumitex. He was an observer to the board of Marrone Bio Innovations prior to its IPO in 2013. Derek holds a B. S. degree in chemistry, with Honors, from Stanford University, a Ph.D. degree in Chemistry and Chemical Biology from Harvard University, and he is a member of Phi Beta Kappa.